Home > Insider Trading > Filing (0001213900-21-067341)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1822711	Pardes Biosciences Inc.	PRDS	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1581754	B. James Tananbaum	900 Larkspur Landing Circle, Suite 150 Larkspur CA 94939	Yes	No	Yes	No
1792204	Foresite Capital Fund V, L.p.	900 Larkspur Landing Circle, Suite 150 Larkspur CA 94939	No	No	Yes	No
1792205	Foresite Capital Opportunity Fund V, L.p.	900 Larkspur Landing Circle, Suite 150 Larkspur CA 94939	No	No	Yes	No
1792206	Foresite Capital Management V, Llc	900 Larkspur Landing Circle, Suite 150 Larkspur CA 94939	No	No	Yes	No
1792207	Foresite Capital Opportunity Management V, Llc	900 Larkspur Landing Circle, Suite 150 Larkspur CA 94939	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-12-22	325,000	$10.00	325,000	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote

Footnotes

Each of Foresite Capital Fund V, L.P. ("Capital Fund V L.P.") and Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V L.P.") purchased 162,500 shares of the Issuer's Class A Common Stock in a block trade at $10 per share on December 22, 2021. Foresite Capital Management V, LLC ("FCMVLLC") and Foresite Capital Opportunity Management V, LLC ("FCOMVLLC") are general partners, respectively, of Capital Fund V L.P. and Opportunity Fund V L.P. Each of FCMVLLC, FCOMVLLC and Dr. Tananbaum, in his capacity as managing member of each of FCMVLLC and FCOMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein. In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of the Issuer's Class A Common Stock were reclassified as common stock.